Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.


Journal

Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 12 02 2022
revised: 23 07 2022
accepted: 26 07 2022
pubmed: 4 8 2022
medline: 9 9 2022
entrez: 3 8 2022
Statut: ppublish

Résumé

Vulvovaginal candidiasis (VVC) is a prevalent infection of the genitourinary tract affecting millions of women worldwide. In the present study, the importance of virulence factors, ERG11 gene mutations, ERG11 gene expression, and plasma membrane ergosterol content for fluconazole resistance in Candida species was investigated in 200 women suspected of vulvovaginitis. Isolated Candida species were identified using the ITS-restriction fragment length polymorphism (ITS-RFLP) technique. Antifungal susceptibility testing was performed according to the CLSI document. ERG11 gene expression was analyzed using real-time PCR. ERG11 gene mutation analysis was performed using sequencing methods, and the ergosterol content of the cell membrane was determined in fluconazole-resistant isolates. Furthermore, the production of phospholipase and proteinase enzymes was evaluated in recurrent and non-recurrent infections. VVC was diagnosed in 101 (50.5%) of the 200 clinical cases, of which 21 (20.8%) were confirmed as RVVC. Candida albicans was the most prevalent species, followed by C. glabrata, C. tropicalis, C. krusei, C. parapsilosis, and C. guilliermondii. Ketoconazole and fluconazole were the most effective drugs against C. albicans among five tested antifungals with MIC ranges between 0.06 and 16 μg/mL and 0.25-64 μg/mL. Substitutions of A114S, Y257H, T123I and A114V were detected in fluconazole-resistant C. albicans. The ergosterol content of the fungal cell membrane and the mean levels of ERG11 gene expression transcript were higher in fluconazole-resistant C. albicans isolates obtained from RVVC than in those obtained from VVC cases. Phospholipase and proteinase were produced in different amounts in all Candida species isolated from VVC and RVVC cases. In this review, our results demonstrated that several molecular mechanisms, including ERG11 gene expression, changes in the cell membrane ergosterol content, and mutations in ERG11 gene alone or simultaneously involved in fluconazole resistance of C. albicans species and the recurrence of VVC.

Identifiants

pubmed: 35921954
pii: S0882-4010(22)00309-6
doi: 10.1016/j.micpath.2022.105696
pii:
doi:

Substances chimiques

Antifungal Agents 0
Fungal Proteins 0
Fluconazole 8VZV102JFY
Phospholipases EC 3.1.-
Peptide Hydrolases EC 3.4.-
Ergosterol Z30RAY509F

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105696

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Aida Esfahani (A)

Department of Medical Mycology, Faculty of Medicine, Tonekabon Branch of Islamic Azad University, Tonekabon, Iran.

Ayatollah Nasrollahi Omran (AN)

Department of Medical Mycology, Faculty of Medicine, Tonekabon Branch of Islamic Azad University, Tonekabon, Iran. Electronic address: ayat51@yahoo.co.in.

Zahra Salehi (Z)

Department of Mycology, Pasteur Institute of Iran, Tehran, 1316943551, Iran.

Masoomeh Shams-Ghahfarokhi (M)

Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-331, Iran.

Masood Ghane (M)

Department of Microbiology, Faculty of Basic Sciences, Tonekabon Branch of Islamic Azad University, Tonekabon, Iran.

Sana Eybpoosh (S)

Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.

Mehdi Razzaghi-Abyaneh (M)

Department of Mycology, Pasteur Institute of Iran, Tehran, 1316943551, Iran. Electronic address: mrab442@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH